Stone Run Capital, LLC Axogen, Inc. Transaction History
Stone Run Capital, LLC
- $250 Billion
- Q2 2024
A detailed history of Stone Run Capital, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Stone Run Capital, LLC holds 23,000 shares of AXGN stock, worth $314,410. This represents 0.07% of its overall portfolio holdings.
Number of Shares
23,000
Previous 25,500
9.8%
Holding current value
$314,410
Previous $206 Million
19.08%
% of portfolio
0.07%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding AXGN
# of Institutions
130Shares Held
35.8MCall Options Held
79.1KPut Options Held
500-
Arrow Mark Colorado Holdings LLC Denver, CO5.12MShares$69.9 Million0.49% of portfolio
-
First Light Asset Management, LLC Edina, MN3.34MShares$45.7 Million2.2% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.31MShares$45.2 Million2.42% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$44.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.52MShares$34.5 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $578M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...